Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of FOLD by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−777,178−100.0%Sold outHolders
Q3 2025777,178$6.12M0.6%−411,820−34.6%ReducedHolders
Q2 20251,188,998$6.81M0.7%−8,344,671−87.5%ReducedHolders
Q1 20259,533,669$77.8M7.4%+2,478,779+35.1%AddedHolders
Q4 20247,054,890$66.5M4.6%−1,191,702−14.5%ReducedHolders
Q3 20248,246,592$88.1M5.2%−2,348,497−22.2%ReducedHolders
Q2 202410,595,089$105.1M6.4%−2,662,197−20.1%ReducedHolders
Q1 202413,257,286$156.2M5.7%−1,571,035−10.6%ReducedHolders
Q4 202314,828,321$210.4M7.5%−2,116,300−12.5%ReducedHolders
Q3 202316,944,621$206.0M9.8%−2,622,340−13.4%ReducedHolders
Q2 202319,566,961$245.8M9.4%+1,220,100+6.7%AddedHolders
Q1 202318,346,861$203.5M8.8%−1,902,928−9.4%ReducedHolders
Q4 202220,249,789$247.2M10.1%−1,469,402−6.8%ReducedHolders
Q3 202221,719,191$226.7M8.8%−439,700−2.0%ReducedHolders
Q2 202222,158,891$238.0M9.1%−170,495−0.8%ReducedHolders
Q1 202222,329,386$211.5M6.6%−386,700−1.7%ReducedHolders
Q4 202122,716,086$262.4M6.0%+1,916,783+9.2%AddedHolders
Q3 202120,799,303$198.6M3.5%00.0%UnchangedHolders
Q2 202120,799,303$200.5M3.0%−314,811−1.5%ReducedHolders
Q1 202121,114,114$208.6M2.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.